Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst JPMorgan highlights valuation resets for Viking and Structure Therapeutics ...
Consider ETFs for this trend. Goldman Sachs initiates Viking Holdings with a Neutral rating, citing high valuation and limited opportunity for growth in new-to-cruise market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback